Compare KRYS & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRYS | FRHC |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.6B |
| IPO Year | 2017 | 1996 |
| Metric | KRYS | FRHC |
|---|---|---|
| Price | $345.32 | $143.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $297.60 | N/A |
| AVG Volume (30 Days) | ★ 242.1K | 180.9K |
| Earning Date | 05-04-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.00 | 79.29 |
| EPS | 1.83 | ★ 2.51 |
| Revenue | $389,130,000.00 | ★ $2,191,291,000.00 |
| Revenue This Year | $38.74 | N/A |
| Revenue Next Year | $32.53 | N/A |
| P/E Ratio | $186.02 | ★ $53.35 |
| Revenue Growth | ★ 33.94 | 6.86 |
| 52 Week Low | $130.17 | $107.98 |
| 52 Week High | $347.67 | $194.01 |
| Indicator | KRYS | FRHC |
|---|---|---|
| Relative Strength Index (RSI) | 73.08 | 49.55 |
| Support Level | $253.89 | $133.76 |
| Resistance Level | N/A | $150.54 |
| Average True Range (ATR) | 12.58 | 8.97 |
| MACD | 3.13 | -0.97 |
| Stochastic Oscillator | 86.78 | 36.02 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.